INTRODUCTION
============

Dysphagia is extremely common following a stroke and affects 45%-65% of patients suffering from acute stroke. Its incidence is related to lesion size and location \[[@B1],[@B2]\]. It is the most significant risk factor for the development of pneumonia and can delay the patient\'s functional recovery \[[@B2],[@B3]\]. Most dysphagia patients recover within 3 weeks of stroke onset, but a recovery is not guaranteed. It may take a more protracted course and may lead to serious complications, such as pneumonia, malnutrition or even death \[[@B4],[@B5],[@B6]\].

A newer treatment modality, neuromuscular electrical stimulation (NMES), provides electrical stimulation on the skin over the throat area. NMES recruits more motor units than volitional contraction and may produce greater gains in muscle strength than exercise alone \[[@B7]\].

Recent studies reported significantly greater improvement for stroke patients in the NMES group compared with other therapeutic methods \[[@B8],[@B9],[@B10]\]. A previous case control study showed that NMES was a helpful treatment for the feeding of acute/subacute stroke patients with tube dependent dysphagia during inpatient rehabilitation. The previous study enrolled acute hemorrhagic or ischemic stroke patients with brain stem lesion and also severe dysphagic patients who had an initial Functional Oral Intake Scale (FOIS) score of 3 or less \[[@B11]\]. The purpose of this randomized study was to prospectively investigate whether combined NMES and traditional dysphagia therapy (TDT) can improve the swallowing function in acute/subacute supratentorial ischemic stroke patients with moderate to severe dysphagia by VFSS.

MATERIALS AND METHODS
=====================

Method
------

Between March 2011 and June 2012, patients were enrolled in this study with a diagnosis of dysphagia by VFSS within 10 days after stroke.

Inclusion criteria were: 1) age between 18 and 80 years; 2) supratentorial ischemic stroke; 3) primary diagnosis of stroke confirmed by computed tomography or magnetic resonance imaging; 4) FOIS score of 5 or less; 5) Korean Mini-Mental State Examination (K-MMSE) score of 21 or higher; and 6) stable underlying disease process.

Exclusion criteria for the trial were as follows: 1) presence of dysphagia before stroke; 2) previous stroke history; 3) unstable cardiopulmonary status, serious psychological disorder or epilepsy; 4) tumor or radiotherapy of the head and neck region; 5) underwent swallowing therapy before participation in the present study; and 6) unstable medical conditions that may interfere with VFSS.

Ninety-two patients were initially screened; 35 subjects who did not meet the inclusion criteria were excluded as study subjects. Fifty-seven patients met all eligibility criteria. The subjects were randomly assigned into two treatment groups. Thirty-one patients (male 22, female 9) were enrolled from the NMES/TDT group and 26 (male 20, female 6) from the TDT group ([Fig. 1](#F1){ref-type="fig"}). Patients were randomly allocated by a computer generated block randomization sequence into two groups, assigning patients to NMES/TDT group or TDT group with a chance of 50% to be assigned to therapy.

All patients received TDT including thermal-tactile stimulation with any combination of lingual-strengthening exercises, laryngeal adduction-elevation exercises, effortful swallow maneuver, Mendelsohn maneuver, Masako maneuver, and Shaker exercises by one speech therapist every day. Thermal-tactile stimulation is a common method that involves stroking or rubbing the anterior faucial pillars with a cold probe prior to having the patient swallow. Both groups received 60 minutes of TDT within a day for 15 days. And NMES (VitalStim Dual Channel Unit and electrodes; Chattanooga Group, Hixson, TN, USA) therapy was applied simultaneously with TDT during the first 30 minutes in the NMES/TDT group. Two sets of electrodes were placed in the infrahyoid area targeting the sternohyoid muscles. NMES intensity was started at 3 mA and increased gradually by 1 mA. We defined the threshold sensibility when a patient continued to complain about discomfort or pain. Patients measured three times of threshold sensibility and swallowing therapist calculated the mean of the three values. The stimulation intensity was then set at 120% of the mean threshold value. A pulse rate of 80 Hz was used with 700 µs duration. Each NMES session was 30 minutes per day, 5 times a week for a total of 3 weeks.

The results were measured using FOIS ([Appendix 1](#APP1){ref-type="app"}). The FOIS is a 7-point ordinal scale reflecting the dietary intake of patients with dysphagia. It has adequate reliability and validity and has been extensively used in clinical studies of dysphagia to measure the functional oral intake \[[@B7],[@B12]\]. We assessed FOIS by VFSS at baseline, after 3, 6, and 12 weeks to compare the degree of improvement between the two groups. All patients were evaluated for dysphagia through VFSS within 10 days (baseline) after stroke and followed-up at 3, 6, and 12 weeks after baseline.

Statistical analysis
--------------------

All statistical analyses were performed using the SPSS ver. 18.0K for Windows (SPSS Inc., Chicago, IL, USA). The Friedman test was used to determine changes in patients\' swallowing function. The FOIS independent sample t-test validation was used to validate between the two groups. The level of statistical significance was set as p-value less than 0.05. The Bonferroni method was used as a post-hoc test. Each category was paired and a Wilcoxon signed-rank test was performed 6 times; at baseline, 3, 6, and 12 weeks after baseline. The level for statistical significance in the post-hoc test was 0.05/6=0.0083.

RESULTS
=======

The mean ages of patients were 63.4±11.4 years for the NMES/TDT group and 66.7±9.5 years for the TDT group. The period from stroke onset to VFSS was 5.5±2.1 and 6.3±2.1 days. There was no significant difference between both groups. Age, sex distribution, stroke lesion, K-MMSE score, and baseline FOIS were similar in both groups and no significant differences were found ([Table 1](#T1){ref-type="table"}).

After 15 sessions of NMES with TDT, all patients were continuously applied with TDT. A change in feeding materials of both groups was described in [Table 2](#T2){ref-type="table"}. Overall, 52 of 57 patients (91.2%) improved enough to no longer require tubal feeding. However, 2 patients of the NMES/TDT group and 3 of the TDT group still required tubal feeding for long-term nutrition. The FOIS of the NMES/TDT group was statistically significant increased in all periods until 12 weeks after treatment ([Table 3](#T3){ref-type="table"}). The TDT group also improved until 12 weeks, but TDT appeared less effective compared with the NMES/TDT group ([Fig. 2](#F2){ref-type="fig"}). The swallowing function of the NMES/TDT group was significantly improved compared with the TDT group in all periods.

Both groups did not show aspiration pneumonia and NMES groups did not show any adverse effects until 12 weeks after stroke.

DISCUSSION
==========

This study demonstrated that early application of NMES and traditional swallowing rehabilitation showed the potential to improve the FOIS scores and the clinical degree of dysphagia for acute/subacute dysphagic stroke patients. Kushner et al. \[[@B11]\] reported NMES with TDT was a beneficial treatment for acute hemorrhage or ischemic stroke patients with tube dependent severe dysphagia. The measured FOIS score of the supratentorial ischemic stroke patients with moderate to severe dysphagia in our study were differently measured than in the previous study. Additionally, our study was not randomized controlled, but block randomized by a computer generated sequence. NMES is a new treatment for dysphagia, involving the application of electrical current across the skin to excite nerve or muscle tissue during a functional task. NMES can increase the suprahyoid muscle size and improve the range of motion, circulation and muscle endurance by increasing the aerobic capacity of the muscle \[[@B13]\]. Recent studies have reported benefits of NMES in the treatment of dysphagia compared with TDT, but most of the studies start dysphagia therapy after 3 weeks of stroke onset \[[@B13],[@B14],[@B15],[@B16],[@B17],[@B18]\].

Previous investigations have shown that signs of aspiration within the first 3 days of a stroke are associated with a delayed swallowing recovery \[[@B19],[@B20],[@B21],[@B22]\]. Recovery from dysphagia after stroke might follow the reorganization of the unaffected motor cortex, but not all patients can recover from dysphagia \[[@B23]\]. Therefore, Odderson et al. \[[@B24]\] showed that an early application of dysphagia therapy for stroke patients was beneficial and cost effective.

Additionally, early NMES application was shown to have more beneficial effect in a dysphagia patient with stroke compared with traditional therapy. Most of the initial tube feeding patients (89.4%) improved enough to remove the nasogastric tube and maintained their oral feeding with no medical complications thereafter. About 40% of patients could return to a pre-stroke oral feeding pattern 3 months after the stroke. Our results suggest that early NMES for acute/subacute dysphagic stroke patients can contribute to a rapid and significant improvement in selected patients. However, five patients (NMES/TDT 2, TDT 3) still required tubal feeding for nutrition at 3-month follow-up. These patients had severe dysphagia at baseline VFSS and did not change at follow-up VFSS. Shaw et al. \[[@B25]\] showed that NMES therapy can improve mild to moderate dysphagia stroke patients, but the most severe dysphagic stroke patients did not gain independence from tubal feeding. Early NMES application with TDT as soon as possible and feeding control guided by VFSS substantially contributed to the improvement of the swallowing function and prevented medical complications, including aspiration pneumonia.

The action mechanisms of NMES have not been fully elucidated yet. NMES is postulated to improve the hyolaryngeal elevation, restore motor function of weak muscles, combat disuse atrophy, enhance sensory awareness and facilitate the muscle contractions \[[@B7]\].

This study has several limitations. First, the study was conducted with a small number of patients. Second, we only measured the functional improvement for a period of 3 to 12 weeks after the stroke. Third, some of the patients had spontaneous recovery, but couldn\'t be excluded.

In conclusion, we compared the functional swallowing outcomes in acute/subacute stroke patients with an early application of NMES combined with TDT and with TDT only. And as a result, early NMES applied patients showed a significant improvement in their swallowing function at 3, 6, and 12 weeks after onset of stroke compared with the TDT only group. This result suggests that the start of NMES combined with TDT as soon as possible after stroke is a more beneficial treatment for acute/subacute stroke patients with dysphagia.
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###### 

General characteristics of patients
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Values are presented as mean±standard deviation or number (%).

NMES/TDT group, patients treated by neuromuscular electrical stimulation combined with traditional dysphagia therapy; TDT group, patients treated by traditional dysphagia therapy only; K-MMSE: Korean-Mini Mental State Examination; FOIS, Functional Oral Intake Scale.

###### 

Comparison of changes in feeding materials after treatment
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Values are presented as number (%).

NMES/TDT group, patients treated by neuromuscular electrical stimulation combined with traditional dysphagia therapy; TDT group, patients treated by traditional dysphagia therapy only.

###### 

Comparison of mean changes in FOIS after treatment
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Values are presented as number (%).

In all periods, NMES/TDT group showed significant improvement compared to TDT group. NMES/TDT group showed improvement of FOIS in all periods. TDT group did not show significant improvement of FOIS in period of 6 weeks to 12 weeks later.

FOIS, Functional Oral Intake Scale; NMES/TDT group, patients treated by neuromuscular electrical stimulation combined with traditional dysphagia therapy; TDT group, patients treated by traditional dysphagia therapy only.

p\<0.0083 (independent sample t-test) significant difference ^a)^between baseline and 3 weeks later in each group, ^b)^between baseline and 6 weeks later in each group, ^c)^between baseline and 12 weeks later in each group, ^d)^between 3 weeks and 6 weeks after stroke in each group, ^e)^between 3 weeks and 12 weeks after stroke in each group, ^f)^between 6 weeks and 12 weeks after stroke in each group.
